COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02748564
Brief Title: Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

First Submitted : April 19, 2016
First Submitted that Met QC Criteria : April 21, 2016
First Posted : April 22, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 25, 2019
Last Update Posted : September 27, 2019